Attachment 2 - Highlights of Prescribing Information -VYTORIN- Ezetimibe and Simvastatin Tablet Organon LLC
NonrulemakingSupporting & Related MaterialFDA-2026-P-5995-0003
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- May 28, 2026
- Agency
- Food and Drug Administration (FDA)
